Allergan will buy French firm that owns wrinkle treatment

Article Abstract:

American pharmaceutical company Allergan Inc. will acquire French company Groupe Corneal Laboratories, in order to gain control of Groupe Corneal's wrinke treatment, Juvederm . Allergan currently owns the U.S. rights to the product; the acquisition will give the company world-wide rights.

France, Allergan Inc., AGN

---

Ranbaxy buys generics maker from Romania

Article Abstract:

Ranbaxy Laboratories Ltd. of India has acquired generic drug company Terapia S.P. of Romania for $324 million. The acquisition provides India's largest drug maker with access to European markets. The pharmaceutical industry is currently experiencing a wave of consolidations.

Romania, India, Ranbaxy Laboratories Ltd., Terapia S.P.

---

Buzz on Bristol-Myers bid could spur share selloff

Article Abstract:

Bristol-Myers Squibb Co. of the United States may be up for a takeover by Sanofi-Aventis S.A. of France. Share price of the American pharmaceuticals giant is up 10 percent.

Securities issued, listed, Securities, Bristol-Myers Squibb Co., BMY, Company securities, SNY, Sanofi-Aventis S.A., Financial report

Similar abstracts:

• Abstracts: Brownian motion approximations for tankage assessment and stock control. A stochastic approach to a case study for product recovery network design
• Abstracts: European banks wrestle with costs, customers, and competition. European banks face technology and cross border challenges
• Abstracts: Self-interest and not benign power-a comment on Hingley's "Power to all our Friends". The power of power in supplier-retailer relationships
• Abstracts: In reaction to stifling theocracy, young Iranians don't want to discuss tradition and history - they want modernity
• Abstracts: An linear programming based lower bound for the simple assembly line balancing problem. Cost-oriented assembly line balancing: Model formulations, solution difficulty, upper and lower bounds

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.